Latest stories on TNGX
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
Business Insider56 · neutralgeneral
H.C. Wainwright raises Tango Therapeutics price target to $68
Investing.com Analyst Ratings61 · neutralanalyst
Tango Therapeutics price target raised to $68 from $66 at H.C. Wainwright
The Fly61 · neutralanalyst
Stifel reiterates Tango Therapeutics stock rating with $40 target
Investing.com Analyst Ratings56 · neutralanalyst
Tango Therapeutics price target raised to $35 from $32 at Guggenheim
The Fly61 · neutralanalyst
Tango Therapeutics: Promising Early Data, But A Long Road Ahead
Seeking Alpha54 · neutralproduct/pr
Guggenheim raises Tango Therapeutics stock price target to $35
Investing.com Analyst Ratings61 · neutralanalyst
Tango Therapeutics, Inc. (TNGX) files 8-K
SEC 8-K50 · neutralgeneral
Why is Tango Therapeutics stock sliding today?
Investing.com Markets42 · neutralgeneral
Tango Therapeutics, Inc. (TNGX) files 8-K
SEC 8-K50 · neutralgeneral
Tango Therapeutics Reports Q2 Eps 37c Consensus 32c
The Fly65 · bullishearnings
Tango Therapeutics GAAP EPS of -$0.37 misses by $0.05
Seeking Alpha34 · bearishearnings
Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
Business Insider56 · neutralgeneral
8-K/A - Tango Therapeutics, Inc. (TNGX) files 8-K
SEC 8-K50 · neutralgeneral
Tango Therapeutics Executive Chairman Weber To Step Down
The Fly42 · neutralgeneral
Tango Therapeutics Announces Executive Chair Barbara Weber’s Departure
TipRanks50 · neutralgeneral
Tango Therapeutics Announces Executive Chair Transition
StockTitan50 · neutralgeneral
Tango Therapeutics, Inc. (TNGX) files 8-K
SEC 8-K50 · neutralgeneral
Most and least shorted mid- to mega-cap healthcare stocks at the end of July
Seeking Alpha47 · neutralgeneral
Tango Therapeutics (TNGX) to Benefit From Vopimetostat + KRAS Inhibitors Combined Revenues
Yahoo Top68 · bullishanalyst
Tango Therapeutics Adds Veteran Biopharma Leader to Board
TipRanks65 · bullishgeneral
Tango Therapeutics, Inc. (TNGX) files 8-K
SEC 8-K50 · neutralgeneral
Tango Therapeutics Appoints Robert Azelby to Board of Directors | TNGX Stock News
StockTitan56 · neutralgeneral